Skip to content

Role of Regulatory T Cells in Pathogenesis of Primary IgA Nephropathy

Role of CD4+CD25+FoxP3+ Regulatory T Cells in Pathogenesis of Primary IgA Nephropathy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00521508
Enrollment
45
Registered
2007-08-28
Start date
2008-04-30
Completion date
2010-09-30
Last updated
2010-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glomerulonephritis, IGA

Keywords

IgA, kidney, Berger'disease, regulatory T cells, pathogenesis of Berger's disease

Brief summary

Along structural IgA abnormalities, hyperproduction of IgA is thought to play a role in the pathogenesis of primary IgA nephropathy. CD4+CD25+Fox3P regulatory T cells are instrumental in suppressing adaptative immune responses, including B cells production of immunoglobulins. We, the researchers at Centre Hospitalier Universitaire de Saine Etienne, will test the hypothesis that IgA production in patients with IgA nephropathy is dysregulated because of a quantitative and/or qualitative defect of CD4+CD25+FoxP3+ regulatory T cells.

Interventions

PROCEDUREgene transcription and cytometry

samply of 30 ml of blood

Sponsors

Centre Hospitalier Universitaire de Saint Etienne
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients with pathogenesis of Berger's disease confirmed by renal biopsy * Glomerular filtration \> 60 ml/min/1,73m2 * Written informed consent * Patient affiliated to social insurance

Exclusion criteria

* Immunosuppressor treatment within 6 months before the study inclusion * Clinical infection within 2 months before the study inclusion * C-reactive protein (CRP) \> 10 mgL-1

Design outcomes

Primary

MeasureTime frame
proportion averages of cells CD4+CD25+CD127 low T in peripheral bloodinclusion

Secondary

MeasureTime frame
average relative expression of genes FoxP3, CTLA4, GITR, IL10, TGF-B, OX40, TIM-1, and TIM-3inclusion

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026